Home / Stocks / PRVA

Privia Health Group (PRVA, Health Care Services) Stock Valuation & Fair Value Quality business with a solid forward outlook

Privia Health Group (PRVA, Health Care Services) trades at a blended P/E of 83.7, about 42% below its historical normal valuation, with a forward growth estimate of 43.3% and a PEG of 1.93. Priced at its historical normal P/E of 143.6 on the same blended earnings, the 2026-09-18 close of $19.85 corresponds to about $34.10 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-09-21
Blended P/E
83.7
Normal P/E
143.6
PEG
1.93
Fwd growth
43.3%
Div yield
0.0%
RSI (14)
23.1
Oversold
Technical context
  • Price $19.10 at the 2026-09-23 close, 6.6% below the 20-day average ($20.46) and 14.9% below the 50-day ($22.45).
  • RSI (14) at 23.1.
  • 52-week range $19.10 to $28.10: the price is 32.0% below the high and at the low.

The Street vs SeerForecast

Wall Street's mean price target for PRVA is $31.67 across 18 analysts, 65.8% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-07-31.

Blended P/E and rating by weekBlended P/E moved from 108.2 to 83.7 between 2026-07-31 and 2026-09-21, against a normal P/E of 143.6, with 0 rating changes over 18 recorded weeks.2026-07-31: P/E 108.2, Fairly valued (recalculated)2026-08-03: P/E 107.2, Fairly valued2026-08-07: P/E 107.2, Fairly valued (recalculated)2026-08-10: P/E 101.4, Fairly valued2026-08-14: P/E 101.4, Fairly valued (recalculated)2026-08-17: P/E 95.8, Fairly valued2026-08-21: P/E 95.8, Fairly valued (recalculated)2026-08-24: P/E 90.3, Fairly valued2026-08-27: P/E 90.3, Fairly valued (recalculated)2026-08-28: P/E 90.3, Fairly valued (recalculated)2026-08-30: P/E 90.3, Fairly valued (recalculated)2026-08-31: P/E 88.3, Fairly valued2026-09-05: P/E 88.3, Fairly valued (recalculated)2026-09-07: P/E 88.2, Fairly valued2026-09-12: P/E 88.2, Fairly valued (recalculated)2026-09-14: P/E 86.7, Fairly valued2026-09-19: P/E 86.7, Fairly valued (recalculated)2026-09-21: P/E 83.7, Fairly valued100.0120.0140.0Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 143.6
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 108.2-25%Fairly valued
2026-09-21P/E 83.7-42%Fairly valued ← now

Frequently asked questions

Is Privia Health Group stock overvalued?

At a blended P/E of 83.7 versus its historical normal P/E of 143.6, Privia Health Group trades about 42% below its typical valuation, with a PEG of 1.93 on 43.3% forward growth. tickerseer currently rates it quality business with a solid forward outlook.

What is Privia Health Group's fair value and PEG?

Privia Health Group trades at a blended P/E of 83.7 against a historical normal P/E of 143.6, a PEG of 1.93, and a forward growth estimate of 43.3%. Priced at its historical normal P/E of 143.6 on the same blended earnings, the 2026-09-18 close of $19.85 corresponds to about $34.10 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Privia Health Group changed?

tickerseer's rating has been fairly valued since 2026-07-31.

What is the analyst price target for Privia Health Group?

The mean Wall Street price target for Privia Health Group is $31.67 across 18 analysts, 65.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track PRVA free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.